For example, miR-449a-5p improves sorafenib-induced apoptosis and reduces angiogenesis in HCC cells by downregulating PEA15, PPP1CA, and TUFT1, and modulating the Akt/ERK signaling pathway [372]. Here, AKT1 is linked to hepatocellular carcinoma.